Focus Financial Network’s Gilead Sciences GILD Stock Holding History

Focus Financial Network’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,481	Closed	-$213K	–	575
2022 Q4	$213K	Sell	2,481 -1,713	-41%	-$136K	0.02%	445
2022 Q3	$259K	Sell	4,194 -785	-16%	-$49.5K	0.02%	395
2022 Q2	$308K	Buy	4,979 +876	+21%	+$54.2K	0.03%	376
2022 Q1	$244K	Buy	4,103 +1,037	+34%	+$66.3K	0.02%	446
2021 Q4	$223K	Buy	+3,066	New	+$211K	0.03%	328
2021 Q2	–	Sell	-3,666	Closed	-$237K	–	409
2021 Q1	$237K	Buy	+3,666	New	+$236K	0.03%	368
2020 Q3	–	Sell	-4,899	Closed	-$377K	–	442
2020 Q2	$377K	Buy	4,899 +509	+12%	+$39K	0.04%	272
2020 Q1	$328K	Buy	+4,390	New	+$303K	0.04%	264
2019 Q2	–	Sell	-3,333	Closed	-$217K	–	371
2019 Q1	$217K	Buy	+3,333	New	+$222K	0.03%	339

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Focus Financial Network's GILD Position: Q1 2023 in Review

Focus Financial Network sold out of Gilead Sciences (GILD) in Q1 2023, closing a stake of 2,481 shares — an estimated $213K sold.

Focus Financial Network first reported a position in GILD in Q1 2019 and held it in 9 quarters. The position peaked at $377K in Q2 2020. 1,735 funds tracked by Wall St. Rank hold GILD as of Q1 2023.

Focus Financial Network reported no remaining Gilead Sciences position as of Q1 2023 after selling out during the quarter.
Focus Financial Network sold 2,481 Gilead Sciences shares in Q1 2023, an estimated $213K.
Focus Financial Network first reported a position in Gilead Sciences in Q1 2019 and held it in 9 quarters.
Focus Financial Network's Gilead Sciences position peaked at $377K in Q2 2020.
1,735 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2023.

Based on Focus Financial Network's 13F filing for Q1 2023, filed 23 Jul 2024.